Kare Chemical Technologies: Funding, Investors & Team (Sep 2026)
Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial processes to produce pure cannabinoids (for example, CBD, THC, CBN, and rare cannabinoids) that are chemically identical to plant‑derived versions but made via synthetic routes.
Kare Chemical Technologies has raised $370k across 1 funding round on record, the most recent a Pre-Seed of $370k announced in May 2026.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Kare Chemical Technologies Company Profile and Key Stats
Latest funding round on record: May 2026.
Kare Chemical Technologies Funding Rounds
Kare Chemical Technologies Founders and Leadership Team
Contact details for the Kare Chemical Technologies team: 1 has a LinkedIn profile.
Start 14-day free trial →Kare Chemical Technologies Funding Compared to Other Health Care Startups
Kare Chemical Technologies' latest round of $370k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kare Chemical Technologies in Health Care and Mississauga
Companies Similar to Kare Chemical Technologies
Cuffway develops medical devices for automated, real-time regulation of endotracheal tube cuff pressure to…
Principal Technologies is a Canadian business that invests in healthcare technologies.
Developing Life Altering Treatments for Patients Suffering from Rare Chronic Diseases.
Optimi Health is a supplier of natural, pharmaceutical-grade psilocybin and synthetic psychedelic compounds.…
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and…
Canadian Coalition for Seniors' Mental Health works to promote seniors' mental health by connecting people,…
Jack.org is a charitable group that instructs and strengthens young pioneers to change the field of mental…
Aplantex produces plant-based active compounds for application in the pharma, cosmetics, and agri-food…
Perimeter Medical Imaging is a medical technology company driven to transform cancer surgery with ultra-high…
Leveljump Healthcare offers radiology solutions for hospitals, emergency rooms, and private clinics. They…
Psyched Wellness is a Canadian-based company improving the health and wellness of millions with high-quality…
Fertility Matters Canada is a fertility care center that provides information and support to couples for…
Kare Chemical Technologies Funding FAQs
What does Kare Chemical Technologies do?
Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial processes to produce pure cannabinoids (for example, CBD, THC, CBN, and rare cannabinoids) that are chemically identical to plant‑derived versions but made via synthetic routes.
How much funding has Kare Chemical Technologies raised?
Kare Chemical Technologies has raised $370k across 1 round on record. The most recent is a Pre-Seed of $370k announced in May 2026.
When did Kare Chemical Technologies last raise funding?
Kare Chemical Technologies' most recent funding round on record is a Pre-Seed of $370k, announced in May 2026.
Who founded Kare Chemical Technologies?
FundedIQ lists Kareem A (Founder) at Kare Chemical Technologies.
Where is Kare Chemical Technologies headquartered?
Kare Chemical Technologies is based in Mississauga, Ontario, Canada.
How many employees does Kare Chemical Technologies have?
Kare Chemical Technologies is in the 1-10 employee band.
How does Kare Chemical Technologies' funding compare to other Health Care startups?
Kare Chemical Technologies' latest round of $370k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Kare Chemical Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kare Chemical Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.